In the realm of fine chemicals and pharmaceutical synthesis, understanding the precise characteristics of key intermediates is crucial for successful production. 7-(3-Chloropropoxy)-4-hydroxy-6-methoxyquinoline-3-carbonitrile (CAS: 214470-66-3) stands out as a pivotal compound, primarily recognized for its role in the synthesis of Bosutinib, an important anticancer medication. NINGBO INNO PHARMCHEM CO.,LTD., a prominent manufacturer and supplier in China, provides insights into the essential properties and applications of this vital chemical.

The compound is typically described as a light yellow to yellow powder, indicating its physical state and color. Its chemical structure, featuring a quinoline core with specific substituents like the chloropropoxy group and a carbonitrile moiety, dictates its reactivity and utility in complex organic synthesis. With a stated assay of ≥98.0%, this intermediate guarantees a high level of purity, which is indispensable for pharmaceutical applications where even minor impurities can affect the final drug product's safety and efficacy. The molecular formula C14H13ClN2O3 and molecular weight of 292.718 further define its chemical identity.

The primary and most significant application of 7-(3-Chloropropoxy)-4-hydroxy-6-methoxyquinoline-3-carbonitrile is as a key intermediate in the manufacturing of Bosutinib. Bosutinib is a tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia (CML). The synthesis of this complex API involves multiple chemical steps, and this specific quinolinecarbonitrile derivative plays an integral role in building the core structure of the drug. Pharmaceutical companies looking to buy this intermediate rely on manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. to provide a product that meets strict quality standards for this critical application.

Beyond its primary use, the unique chemical structure of 7-(3-Chloropropoxy)-4-hydroxy-6-methoxyquinoline-3-carbonitrile may also find applications in other areas of pharmaceutical research and development, particularly in the synthesis of novel quinoline-based compounds with potential therapeutic activities. As a reliable supplier from China, NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to supporting these endeavors by providing high-quality chemical intermediates. Our manufacturing capabilities ensure that we can meet the diverse needs of the global pharmaceutical industry, offering competitive pricing and consistent product quality.

In summary, 7-(3-Chloropropoxy)-4-hydroxy-6-methoxyquinoline-3-carbonitrile is a crucial intermediate in the pharmaceutical supply chain, primarily for the synthesis of Bosutinib. Its well-defined properties and high purity make it an essential component for drug manufacturers. NINGBO INNO PHARMCHEM CO.,LTD. is committed to being your trusted source for this and other pharmaceutical intermediates. Contact us to discuss your requirements and explore our comprehensive product portfolio.